News | Breast Imaging | October 04, 2017

Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas

Solis Mammography and HCA Healthcare Gulf Coast Division will deliver best-in-practice breast health screenings and diagnostics

Joint Venture Partnership Opening 16 New Breast Screening Sites in Texas

October 4, 2017 — HCA Healthcare Gulf Coast Division and Solis Mammography have entered into a joint venture agreement to make breast health diagnostic services more accessible and convenient across the greater Houston region. The collaboration will result in 16 local sites by the end of 2018, including the Oct. 2 grand opening of a new dedicated breast health center at HCA-affiliated The Woman’s Hospital of Texas.

The collaboration builds on the success of a three-year partnership between Medical City Healthcare (HCA’s North Texas Division) and Solis Mammography at more than a dozen centers in the Dallas/Fort Worth metroplex.

“Understanding the critical importance of preventative screening to overall breast health, we know early detection through high-quality screening is key. We also know that offering easy access, convenient locations and patient-centric services makes it easier for women to get the preventative care that offers the best possible options for treatment, minimizing the stress, cost and risks that come with later stage diagnosis,” said Stephen Nesbit, DO, HCA Healthcare Gulf Coast Division chief medical officer.

The partnership kicks off with three existing locations located in Northwest Houston, Katy and Sugar Land and the opening of the new center in the newly refurbished One Fannin Center located next to The Woman’s Hospital of Texas. The new space offers more than 6,000 square feet of breast screening and diagnostic 3-D mammography computer-aided detection, breast ultrasound, stereotactic breast biopsy, ultrasound-guided biopsy, breast magnetic resonance imaging (MRI) and bone density scanning – all in an environment uniquely designed to promote patient relaxation and peace of mind.

Providing radiologist coverage for the centers in the region will be Woman’s Radiology Associates and Rose Imaging Specialists, both under the direction of Solis Chief Medical Officer Stephen Rose, M.D. “From my own practice, I’ve seen dramatic improvement in early detection and reduced recalls from 3-D – providing greater patient care for the women we serve,” said Rose.

Through the new partnership, Houston-area women will have greater access to upgraded technology, research-based clinical protocols, convenient locations and an enhanced center experience, including:

  • Seamless continuum of care through The Woman’s Hospital of Texas and HCA Healthcare Gulf Coast Division facilities, if treatment is needed beyond screening and diagnostic imaging;
  • Exceptional clinical accuracy through breast specialization (a practice shown to dramatically increase the accuracy of a mammogram);
  • The most advanced technology available, including 3-D mammography (also known as digital breast tomosynthesis), scheduling software and data management;
  • Warm and welcoming breast imaging centers with decor, music, artwork and aesthetics designed for today’s female consumer;
  • Easier ability to book appointments through real-time, 24/7 access to online scheduling;
  • Improved patient conveniences, like ease of center access, convenient locations, free parking, valet parking, tablet registration, complimentary Wi-Fi and quick turnaround time in the center – typically less than 30 to 40 minutes; and
  • Fast, accurate results by email within 24-48 hours of the visit.

For more information: www.solismammo.com

Related Content

Illinois Governor Approves State Breast Density Reporting Bill Into Law
News | Breast Density | August 13, 2018
Illinois Gov. Bruce Rauner approved the Illinois Breast Density Reporting Law (Public Act 100-0749) on Aug. 10, 2018...
PET Tracer Identifies Estrogen Receptor Expression Differences in Breast Cancer Patients
News | PET Imaging | August 09, 2018
In metastatic breast cancer, prognosis and treatment is largely influenced by estrogen receptor (ER) expression of the...
iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis
Technology | Breast Density | August 08, 2018
iCAD announced U.S. Food and Drug Administration (FDA) clearance of its latest artificial intelligence (AI) software...
Cardiac Imaging Reveals Roots of Preeclampsia Damage in Pregnant Women
News | Women's Health | August 07, 2018
Johns Hopkins researchers say a heart imaging study of scores of pregnant women with the most severe and dangerous form...
Cardiac Monitoring a Higher Priority for High-Risk Breast Cancer Patients
News | Cardio-oncology | August 07, 2018
August 7, 2018 — While heart failure is an uncommon complication of...
Hologic Acquires Digital Specimen Radiography Company Faxitron Bioptics

VisionCT 3-D breast specimen-designated computed tomography (CT) system. Image courtesy of Faxitron Bioptics.

News | Breast Imaging | July 31, 2018
Hologic Inc. announced it has completed the acquisition of Faxitron Bioptics, a privately-held leader in digital...
Konica Minolta Hosting Lunch and Learn at 23rd Annual Mammography Meeting in Santa Fe
News | Breast Imaging | July 31, 2018
Konica Minolta Healthcare Americas Inc. will sponsor a lunch and learn featuring its Exa Mammo platform during the 23rd...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
The Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. The FDA granted approval of the Sentimag System to Endomagnetics Inc.

The  Endomagnetics' Magtrace and Sentimag Magnetic Localization System uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal.

Technology | Women's Health | July 24, 2018
July 24, 2018 — The U.S.
Overlay Init